Héma-Québec to Reimburse HyQvia® for the Treatment of Immunodeficiencies in Adult and Pediatric Patients Over 2 Years of Age

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®- (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) as a replacement therapy for primary humoral immunodeficiency (PI) or secondary humoral immunodeficiency (SI) – to its list of plasma products distributed in Quebec.1The treatment will now be reimbursed for […]

Porter Airlines, BMO and Mastercard Accelerate Canadians’ Travel Rewards Journey with New Credit Card Program

— New VIPorter travel credit card to launch in spring 2025 Porter Airlines, BMO and Mastercard are partnering to accelerate Canadians' travel rewards journey. A new BMO VIPorter Mastercard suite will be available to Canadians in spring 2025. Driven by a shared commitment to exceed customer expectations around service and customer loyalty, this collaboration will

Rezolve Ai Secures $30 Million Loan to Drive Growth and Accelerate Momentum

(NasdaqGM:RZLV), NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in AI-driven retail and eCommerce solutions, announces the successful arrangement of a $30 million unsecured loan facility with Joh. Berenberg, Gossler & Co. KG (“Berenberg”). The Company believes that this strategic funding underscores the considerable momentum in Rezolve Ai's

60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

(NASDAQ:SXTP),(NASDAQ:SXTPW), WASHINGTON, Jan. 29, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,021,549 shares of its common stock at a purchase

Golden Ridge Announces Proposed C$2-Million Best Efforts Private Placement in Furtherance of Previously Announced Acquisition of a Majority Interest in Brazilian Mining Producer MM Group LTDA.

(TSX-V:GLDN), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia , Jan. 29, 2025 (GLOBE NEWSWIRE) — Golden Ridge Resources Ltd. (“Golden Ridge” or the “Company“) (TSX-V: GLDN) is pleased to announce that it has entered into an engagement agreement with Haywood Securities Inc. (“Haywood”

Southern Realty Trust Originates $41.0 Million Bridge Loan for Dornin Investment Group on Mixed-Use Asset in One of South Florida’s Medical Hubs

WEST PALM BEACH, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) — Southern Realty Trust Inc. (“SRT” or the “Company”), an affiliate of TCG Real Estate, today announced that it has committed $10.3 million to a $41.0 million note-on-note bridge loan. This loan is for the full repayment of an existing senior mortgage on a mixed-use asset,

Sunrise Realty Trust Inc. Originates $41.0 Million Bridge Loan for Dornin Investment Group on Mixed-Use Asset in One of South Florida’s Medical Hubs

(NASDAQ:SUNS), WEST PALM BEACH, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or “the Company”) (Nasdaq: SUNS), an affiliate of TCG Real Estate, today announced that it has committed $30.8 million to a $41.0 million note-on-note bridge loan. This loan is for the full repayment of an existing senior mortgage on

CALIFORNIA BANCORP REPORTS NET INCOME OF $16.8 MILLION FOR THE FOURTH QUARTER AND $5.4 MILLION FOR THE FULL YEAR OF 2024

(NASDAQ:BCAL), San Diego, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — California BanCorp (“us,” “we,” “our,” or the “Company”) (NASDAQ: BCAL), the holding company for California Bank of Commerce, N.A. (the “Bank”) announces its consolidated financial results for the fourth quarter and full year of 2024. The Company reported net income of $16.8 million, or $0.51

OKYO Pharma to Complete Enrollment of Neuropathic Corneal Pain Trial by End of Second Quarter

(NASDAQ:OKYO), LONDON and NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease (DED), a multi-billion-dollar market, today announces a clinical update

zSpace’s Career Readiness Solution powered by Career Coach AI Wins Prestigious District Administration Top EdTech Products Award for 2025

(NasdaqGM:ZSPC), SAN JOSE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — zSpace (NASDAQ: ZSPC), a leader in augmented and virtual reality solutions for education, proudly announces that its groundbreaking Career Readiness Solution powered by Career Coach AI, has been named a winner of the 2025 District Administration Top EdTech Products Award. The solution earned recognition in

Scroll to Top